Put companies on watchlist
Abbott Laboratories
ISIN: US0028241000
WKN: 850103
About
Company Snapshot
New: Enable Investor Alerts
Be informed about new publications
New: AI Factsheet

Corporate News meets AI! 
Content analysis and summary

Abbott Laboratories · ISIN: US0028241000 · PR Newswire (ID: 20240925CG15055)
25 September 2024 03:00PM

Abbott Hosts Conference Call for Third-Quarter Earnings


ABBOTT PARK, Ill., Sept. 25, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) will announce its third-quarter 2024 financial results on Wednesday, Oct. 16, before the market opens. 

The announcement will be followed by a live webcast of the earnings conference call at 8 a.m. Central time (9 a.m. Eastern) and will be accessible through Abbott's Investor Relations website at www.abbottinvestor.com. An archived edition of the call will be available later that day.

About Abbott:

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.

Connect with us at www.abbott.com and on LinkedInFacebookInstagramX and YouTube.

 

Cision View original content:https://www.prnewswire.com/news-releases/abbott-hosts-conference-call-for-third-quarter-earnings-302258104.html

SOURCE Abbott

Visual performance / price development - Abbott Laboratories
Smart analysis and research tools can be found here.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Contact:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942